Author

edelhealth

New Information Guides Available for Patients Diagnosed with Inflammatory Bowel Disease

N

“Life and IBD” guides help close the communication gap between patients and physicians Vienna, Austria, 20 October 2008 – To help those with inflammatory bowel disease (IBD) be better informed and involved in managing their disease, the European Foundation of Crohn’s & Ulcerative Colitis Associations (EFCCA) has launched a new series of guides titled “Life and IBD”. For over one...

Abbott’s HUMIRA® Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis

A

Abbott’s HUMIRA® Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis In Clinical Trials, Patients Taking HUMIRA Saw Significant and Sustained Skin Clearance ABBOTT PARK, Ill., Dec. 20, 2007 — Abbott has received marketing authorization from the European Commission for the use of HUMIRA® (adalimumab) as a treatment for moderate-to-severe plaque psoriasis...